Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nucleus Claims Study: Evaluating the User Performance and Experience of Nucleus Pen vs. Commercially Available Pen Needle

NCT03267264 is registered in ClinicalTrials.gov with Becton, Dickinson and Company as lead sponsor.

NCT NCT03267264
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03267264 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nucleus Claims Study: Evaluating the User Performance and Experience of Nucleus Pen vs. Commercially Available Pen Needle
Lead sponsor
Becton, Dickinson and Company
Phase
Not applicable
Overall status
Completed
Start date
September 1, 2017
Completion date
May 24, 2018
Enrollment
248 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes